lymphoma, b cell

Showing 1 - 6 of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma, B Cell Trial in Houston (KA2237)

Completed
  • Lymphoma, B Cell
  • Houston, Texas
    MD Anderson Cancer Center
Feb 4, 2019

Lymphoma, B Cell Trial in Changzhou (IL-2 pre-treated CD19 cells, IL-7/IL-15 pre-treated CD19 cells)

Unknown status
  • Lymphoma, B Cell
  • IL-2 pre-treated CD19 cells
  • IL-7/IL-15 pre-treated CD19 cells
  • Changzhou, Jiangsu, China
    First People's Hospital of Changzhou
Dec 12, 2016

Lymphoma, B Cell Trial (intrathecal rituximab)

Withdrawn
  • Lymphoma, B Cell
  • intrathecal rituximab
  • (no location specified)
Mar 27, 2015

Lymphoma, B Cell Trial in Bellinzona (high dose methotrexate, high dose cytarabine, radiotherapy)

Completed
  • Lymphoma, B Cell
  • high dose methotrexate
  • +2 more
  • Bellinzona, Switzerland
    Oncology Institute of Southern Switzerland (IOSI)
Mar 27, 2015

Neoplastic Meningitis, Lymphoma, B Cell Trial in Durham (cytarabine liposome injection)

Terminated
  • Neoplastic Meningitis
  • Lymphoma, B Cell
  • cytarabine liposome injection
  • Durham, North Carolina
    Duke University Medical Center
Jun 7, 2013

Lymphoma, B Cell Trial in Bellinzona (rituximab, CHOP, intrathecal methotrexate)

Completed
  • Lymphoma, B Cell
  • Bellinzona, Switzerland
    Oncology Institute of Southern Switzerland (IOSI)
Jul 21, 2009